The Purpose of This Study is to Determine the Safety, Tolerability, and Pharmacokinetics of Brexpiprazole Long-acting Injection Following a Single Administration in Healthy Subjects/Patients With Schizophrenia.
Abroad (travel likely)RecruitingPHASE1
Conditions
Schizophrenia Disorders
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Beijing Anding Hospital Capital Medical University, Beijing, Beijing Municipality, China
Contact: Principal Investigator (Gang Wang)